AAD 2026Abstract 75810
Long-term efficacy, complete scalp hair regrowth, and normal body hair and nails in patients with alopecia areata (AA) receiving ritlecitinib 50 mg once daily up to 3 years in the ALLEGRO clinical trial program
King B, Sinclair R, Rudnicka L, Vañó-Galvan S, Piraccini BM, Ohyama M, Wu W, Wolk R, Wajsbrot D, Tran H, Lejeune A
AAD Annual Meeting 2026Denver, 27–31 Mar 2026 · published in JAAD 6 Jul 2026
Abstract
The abstract’s text is on the JAAD website.
DOI 10.1016/j.jaad.2026.04.1163 · Not in PubMed: details from Crossref